Asheville, North Carolina – May 19, 2015 Avadim Technologies Inc., manufacturer of “Theraworx®”, announced today that Dr. Timothy L. Wiemken, leading researcher and educator in the areas of infection prevention, epidemiology, and biostatistics, has agreed to join Avadim’s Medical & Science Advisory Board.
Chairman and CEO, Stephen Woody said, “We already know Dr. Wiemken well. He has been working with our product line, and continues to build our clinical database validating Theraworx® Techology and its potential to assist healthcare facilities with hospital-acquired condition challenges. Dr. Wiemken’s expertise and experience will be invaluable.”
Dr. Wiemken stated that, “It is my pleasure to join the Theraworx Medical & Science Board. My prior work with Theraworx products demonstrates that their technology shows great promise in addressing the clinical and financial challenges of today’s healthcare environment. I am excited about having a closer association with their team.”
About Timothy L. Wiemken:
Dr. Wiemken received his BA in Microbiology from Southern IL University, his MPH in Epidemiology from St. Louis University, and his PhD from the University of Louisville. He currently serves the University of Louisville as Assistant Professor, Department of Medicine, is the Director of the University of Louisville Global Health Research Organization Computational Epidemiology Unit, and Director of their Healthcare Epidemiology Research Program. He has published more than 200 books, book chapters, peer-reviewed journal articles, and posters, on various topics in his areas of expertise. His significant body of work under grants from both public and private institutions has contributed greatly to our knowledge of numerous disease states and conditions. He is a member of both the Annual Conference Committee of the Association for Professionals in Infection Control and Epidemiology (APIC) and the Guidelines Committee of the Society for Healthcare Epidemiology of America (SHEA). Finally, he is a Colonel in the Honorable Order of Kentucky Colonels.
Avadim’s patented Theraworx® products and patent-pending protocols have demonstrated a proven ability to help hospitals control hospital-acquired conditions. The unique Theraworx formula helps preserve the body’s natural skin function, by preventing dry skin and helping to maintain the natural acidic, anti-microbial nature of the skin’s outermost layer.
For more information on Theraworx, visit www.theraworx.com.
About Avadim Technologies, Inc.
Avadim Technologies, Inc. was formed in 2007, with a simple vision of improving patient care. Our desire is to transform standard health care practices with our safe and effective patent pending technology, with the ultimate goal of fighting unnecessary infections on a global level. The name Avadim means “to serve”, providing opportunity for global outreach and giving back. To learn more about Avadim Technologies, Inc., visit https://theraworxprotect.com and follow @theraworx.
The Buzz, LLC
Chief Financial Officer
Avadim Technologies Inc.